- Home
- ZURA vs CRUS Comparison
ZURA vs CRUS Comparison
Compare ZURA & CRUS Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
- Machine Learning Prediction
- ML Decision
- ZURA
- CRUS
- Stock Information
- Founded
- ZURA 2022
- CRUS 1984
- Country
- ZURA United States
- CRUS United States
- Employees
- ZURA N/A
- CRUS N/A
- Industry
- ZURA Biotechnology: Biological Products (No Diagnostic Substances)
- CRUS Semiconductors
- Sector
- ZURA Health Care
- CRUS Technology
- Exchange
- ZURA Nasdaq
- CRUS Nasdaq
- Market Cap
- ZURA 69.9M
- CRUS 5.5B
- IPO Year
- ZURA N/A
- CRUS 1989
- Fundamental
- Price
- ZURA $1.31
- CRUS $104.87
- Analyst Decision
- ZURA Buy
- CRUS Strong Buy
- Analyst Count
- ZURA 7
- CRUS 5
- Target Price
- ZURA $14.33
- CRUS $126.40
- AVG Volume (30 Days)
- ZURA 708.2K
- CRUS 515.4K
- Earning Date
- ZURA 08-08-2025
- CRUS 08-05-2025
- Dividend Yield
- ZURA N/A
- CRUS N/A
- EPS Growth
- ZURA N/A
- CRUS 22.45
- EPS
- ZURA N/A
- CRUS 6.00
- Revenue
- ZURA N/A
- CRUS $1,896,077,000.00
- Revenue This Year
- ZURA N/A
- CRUS N/A
- Revenue Next Year
- ZURA N/A
- CRUS $7.88
- P/E Ratio
- ZURA N/A
- CRUS $17.36
- Revenue Growth
- ZURA N/A
- CRUS 5.99
- 52 Week Low
- ZURA $0.97
- CRUS $75.83
- 52 Week High
- ZURA $5.07
- CRUS $147.46
- Technical
- Relative Strength Index (RSI)
- ZURA 59.63
- CRUS 49.03
- Support Level
- ZURA $1.00
- CRUS $102.33
- Resistance Level
- ZURA $1.45
- CRUS $111.48
- Average True Range (ATR)
- ZURA 0.10
- CRUS 2.83
- MACD
- ZURA 0.03
- CRUS -0.40
- Stochastic Oscillator
- ZURA 68.89
- CRUS 24.10
About ZURA Zura Bio Limited
Zura Bio Ltd is a clinical-stage, multi-asset immunology company developing novel dual-pathway antibodies for autoimmune and inflammatory diseases. It is developing three assets which have completed Phase I/Ib studies and are Phase II ready. It is developing a portfolio of therapeutic indications for tibulizumab and torudokimab with a goal of demonstrating their efficacy, safety, and dosing convenience in autoimmune and inflammatory diseases.
About CRUS Cirrus Logic Inc.
Cirrus Logic Inc is a provider of integrated circuits for audio and voice signal processing applications. The firm's products are organized into two streams: portable audio products, and HPMS Products. These products include aAmplifiers, codecs, smart codecs, analog-to-digital converters, digital-to-analog converters and standalone digital signal processors, Camera controllers, haptics and sensing solutions, and battery and power ICs. Roughly half of the firm's revenue is generated in China, with the rest coming from the United States, Europe, South Korea, and countries across the world.